CXCL13 and cancer: By employing our pipeline to thousands of patients from various external data sets, we demonstrated that estimated TLS ratios significantly correlated with established TLS-associated molecular signatures, including B cell abundance and CXCL13 expression, suggesting the reliability of our approach to segment and quantify TLSs across multiple cancer types.